⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10181957 | 0.83 | LMNA (0.31) | — | |
| SCHEMBL21386222 | 0.77 | — | — | |
| SCHEMBL15083640 | 0.74 | MAPK1 (0.33) | — | |
| SCHEMBL23871973 | 0.67 | TP53 (0.43) | — | |
| SCHEMBL16571254 | 0.67 | — | — | |
| SCHEMBL13149692 | 0.65 | KEAP1 (0.34) | — | |
| SCHEMBL2664200 | 0.65 | — | — | |
| SCHEMBL23450336 | 0.65 | — | — | |
| SCHEMBL23763496 | 0.65 | — | — | |
| SCHEMBL24506017 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020132561-A1 | TARGETED PROTEIN DEGRADATION | C4 THERAPEUTICS, INC. (US) | 2020-06-25 | — | — | WO | disclosed |
| WO-2017060925-A1 | NOVEL PIPECOLIC ACID CO-CRYSTALS OF DAPAGLIFLOZIN AND PROCESS FOR THE PREPARATION THEREOF | HARMAN FINOCHEM LIMITED (IN) | 2017-04-13 | — | — | WO | disclosed |
| EP-2014285-A1 | NPYY5 antagonists | Shionogi&Co., Ltd. (JP) | 2009-01-14 | — | — | EP | disclosed |